surpass tirzepatide Efficacy and safety of monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial SURPASS-5: Tirzepatide lowers HbA1c in
Pay in 4 interest-free payments of $5.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11


00243-1/asset/3e6344be-cfd8-4182-b471-5c447dcc78dd/main.assets/gr1_lrg.jpg)

























